Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
KKW To, S Sridhar, KHY Chiu, DLL Hung… - Emerging microbes & …, 2021 - Taylor & Francis
Without modern medical management and vaccines, the severity of the Coronavirus
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …
Current and innovative methods for the diagnosis of COVID‑19 infection
Abstract The Coronavirus Disease 2019 (COVID‑19) pandemic has forced the scientific
community to rapidly develop highly reliable diagnostic methods in order to effectively and …
community to rapidly develop highly reliable diagnostic methods in order to effectively and …
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate
A Addetia, KHD Crawford, A Dingens… - Journal of clinical …, 2020 - Am Soc Microbiol
The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies …
identification of immunological correlates of protection in humans. However, to date, studies …
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression
N Arshad, M Laurent-Rolle… - Proceedings of the …, 2023 - National Acad Sciences
Major histocompatibility complex class I (MHC-I) molecules, which are dimers of a
glycosylated polymorphic transmembrane heavy chain and the small-protein β2 …
glycosylated polymorphic transmembrane heavy chain and the small-protein β2 …
[HTML][HTML] Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection
The outbreak of 2019-novel coronavirus disease (COVID-19), caused by SARS-CoV-2,
started in late 2019; in a short time, it has spread rapidly all over the world. Although some …
started in late 2019; in a short time, it has spread rapidly all over the world. Although some …
A novel cell culture system modeling the SARS-CoV-2 life cycle
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the global
pandemic of COVID-19. SARS-CoV-2 is classified as a biosafety level-3 (BSL-3) agent …
pandemic of COVID-19. SARS-CoV-2 is classified as a biosafety level-3 (BSL-3) agent …
SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport through interactions with Rae1 and Nup98
ABSTRACT RNA viruses that replicate in the cytoplasm often disrupt nucleocytoplasmic
transport to preferentially translate their own transcripts and prevent host antiviral responses …
transport to preferentially translate their own transcripts and prevent host antiviral responses …
Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of
coronavirus disease 2019 (COVID‐19), has caused millions of deaths in the past two years …
coronavirus disease 2019 (COVID‐19), has caused millions of deaths in the past two years …
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
S Kakavandi, I Zare, M VaezJalali, M Dadashi… - Cell Communication and …, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is caused by a new member of the
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
TP Peacock, R Penrice-Randal… - Journal of General …, 2021 - microbiologyresearch.org
SARS-CoV-2 is thought to have originated in the human population from a zoonotic spillover
event. Infection in humans results in a variety of outcomes ranging from asymptomatic cases …
event. Infection in humans results in a variety of outcomes ranging from asymptomatic cases …